Veragrow SAS

Founded in 2019, Veragrow is engaged in the production of biostimulants from high-quality vermicompost. In November 2025, Veragrow raised EUR 2. 25 million in venture funding led by Odyssée Venture, with the participation from Normandie Participations and CEN Innovation, and other investors. Veragrow produces biostimulants derived from high-quality vermicompost, leveraging a unique extraction process to create products that enhance plant growth and resilience.

Their product line includes VERALEAF® for foliar applications, VERASPIDA® for seed treatments, and VERATERRA® for soil enhancement, addressing the needs of diverse agricultural sectors across Europe and North America. Veragrow's business model focuses on B2B transactions, distributing biostimulant products to agricultural retailers, wholesalers, and directly to farmers. Revenue is generated from the sale of product lines including VERALEAF®, VERASPIDA®, and VERATERRA®. The company operates on a bulk purchase system, fostering ongoing partnerships with customers, although specific pricing details are undisclosed.

In December 2025, Veragrow raised USD 5. 2 mn from investors including Odyssée Venture and Normandie Participations. The funds will be utilized to enhance its sales network and expand distribution both domestically and internationally. The company also plans to increase production capacity at its facility in Val-de-Reuil and advance research and development initiatives to meet growing market demand.